255 related articles for article (PubMed ID: 10466742)
1. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines.
Oda N; Minoguchi K; Yokoe T; Hashimoto T; Wada K; Miyamoto M; Tanaka A; Kohno Y; Adachi M
Life Sci; 1999; 65(8):763-70. PubMed ID: 10466742
[TBL] [Abstract][Full Text] [Related]
2. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
Oda N; Minoguchi K; Tanaka A; Yokoe T; Minoguchi H; Matsuo H; Nakashima M; Tasaki T; Adachi M
Clin Exp Allergy; 2002 Dec; 32(12):1782-6. PubMed ID: 12653172
[TBL] [Abstract][Full Text] [Related]
3. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response.
Yanagihara Y; Kiniwa M; Ikizawa K; Shida T; Matsuura N; Koda A
Jpn J Pharmacol; 1993 Jan; 61(1):31-9. PubMed ID: 8382323
[TBL] [Abstract][Full Text] [Related]
4. The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells.
Hsu LW; Yang CH; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Tsao FK; Chen CL
Transpl Immunol; 2007 Nov; 18(2):108-14. PubMed ID: 18005853
[TBL] [Abstract][Full Text] [Related]
5. IPD-1151T (suplatast tosilate) inhibits interleukin (IL)-13 release but not IL-4 release from basophils.
Shichijo M; Shimizu Y; Hiramatsu K; Togawa M; Inagaki N; Takagi K; Nagai H
Jpn J Pharmacol; 1999 Apr; 79(4):501-4. PubMed ID: 10361893
[TBL] [Abstract][Full Text] [Related]
6. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
[TBL] [Abstract][Full Text] [Related]
8. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1). Regulation of murine IgE response.
Yanagihara Y; Kiniwa M; Ikizawa K; Yamaya H; Shida T; Matsuura N; Koda A
Jpn J Pharmacol; 1993 Jan; 61(1):23-30. PubMed ID: 8382322
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
Kurokawa M; Kawazu K; Asano K; Fumio K; Mita A; Adachi M
Mediators Inflamm; 2001 Dec; 10(6):333-7. PubMed ID: 11817674
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
Asano K; Mizutani T; Shimane T; Hisano M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2000; 9(2):77-84. PubMed ID: 10958380
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of IPD-1151T (suplatast tosilate) on mast cell induction from normal mouse spleen cells].
Kouno S; Adachi M; Asano K; Okamoto K; Takahashi T
Arerugi; 1992 Oct; 41(10):1488-91. PubMed ID: 1336362
[TBL] [Abstract][Full Text] [Related]
12. [Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].
Matsuura N; Mori H; Nagai H; Koda A
Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):495-501. PubMed ID: 1282894
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes.
Konno S; Adachi M; Asano K; Gonogami Y; Ikeda K; Okamoto K; Takahashi T
Eur J Pharmacol; 1994 Jun; 259(1):15-20. PubMed ID: 7957588
[TBL] [Abstract][Full Text] [Related]
14. An annexin 1 (ANXA1)-derived peptide inhibits prototype antigen-driven human T cell Th1 and Th2 responses in vitro.
Kamal AM; Smith SF; De Silva Wijayasinghe M; Solito E; Corrigan CJ
Clin Exp Allergy; 2001 Jul; 31(7):1116-25. PubMed ID: 11468004
[TBL] [Abstract][Full Text] [Related]
15. Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
Zhao GD; Yokoyama A; Kohno N; Sakai K; Hamada H; Hiwada K
Int Arch Allergy Immunol; 2000 Feb; 121(2):116-22. PubMed ID: 10705221
[TBL] [Abstract][Full Text] [Related]
16. Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
Boucher W; Kempuraj D; Cao J; Papaliodis D; Theoharides TC
J Urol; 2007 Mar; 177(3):1186-90. PubMed ID: 17296442
[TBL] [Abstract][Full Text] [Related]
17. Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T).
Tsukagoshi H; Nagashima M; Horie T; Oyama T; Yoshii A; Sato T; Iizuka K; Dobashi K; Mori M
Intern Med; 1998 Dec; 37(12):1064-7. PubMed ID: 9932643
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
19. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
Konno S; Asano K; Gonokami Y; Kurokawa M; Kawazu K; Adachi M
Arerugi; 1995 May; 44(5):556-61. PubMed ID: 7619009
[TBL] [Abstract][Full Text] [Related]
20. Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation.
Lee YL; Fu CL; Ye YL; Chiang BL
Scand J Immunol; 1999 Mar; 49(3):229-36. PubMed ID: 10102639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
